TP53 and cancer: Significantly higher levels of immune infiltrate were measured in LUSC from females than from males, for both wt and mutant TP53 (Figure 6C, p = 0.02; Figure 6D, p < 0.01) in contrast to LUAD, where significance was only seen for wt TP53 cancers (Figure 2C,D).